4.4 Review

Review: The role of IL-6 in immunotherapy of non-small cell lung cancer (NSCLC) with immune-related adverse events (irAEs)

Related references

Note: Only part of the references are listed.
Article Oncology

Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade

Chipman R. G. Stroud et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2019)

Article Oncology

Management of Immunotherapy-Related Toxicities. Version 1.2019

John A. Thompson et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)

Article Oncology

A severe case of refractory esophageal stenosis induced by nivolumab and responding to tocilizumab therapy

Alice Horisberger et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)

Article Clinical Neurology

Beneficial effect of tocilizumab in myasthenia gravis refractory to rituximab

Dagur Ingi Jonsson et al.

NEUROMUSCULAR DISORDERS (2017)

Review Oncology

Immune-based Therapies for Non-small Cell Lung Cancer

Hind Rafei et al.

ANTICANCER RESEARCH (2017)

Meeting Abstract Oncology

Systemic inflammatory response syndrome (SIRS) with immune checkpoint inhibitors

Nitika Sharma et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

Article Cell Biology

Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Marco L. Davila et al.

SCIENCE TRANSLATIONAL MEDICINE (2014)

Article Biotechnology & Applied Microbiology

A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer

Trevor J. Bayliss et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2011)

Article Oncology

Increased Levels of Circulating Interleukin 6, Interleukin 8, C-Reactive Protein, and Risk of Lung Cancer

Sharon R. Pine et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)

Article Ophthalmology

Efficacy of Tocilizumab in Two Patients with anti-TNF-alpha Refractory Uveitis

Aurore Muselier et al.

OCULAR IMMUNOLOGY AND INFLAMMATION (2011)

Review Rheumatology

Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor

Jean-Michel Dayer et al.

RHEUMATOLOGY (2010)

Article Oncology

Serum Concentrations of Cytokines and Lung Cancer Survival in African Americans and Caucasians

Lindsey Enewold et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)

Article Multidisciplinary Sciences

An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer

FM Brichory et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)